Is CNMD or CV more undervalued in 2026?

CirclFi compares CONMED Corporation (CNMD) and CapsoVision, Inc. (CV) using 13 institutional-grade valuation models. CNMD has a Quality of Company score of 8.3/10 while CV scores 5.7/10.

Which is a better buy — CNMD or CV?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CNMD and CV valuations compare?

CNMD at $35.70 and CV at $6.78 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CNMD vs CV Valuation Comparison 2026 — Intrinsic Value Analysis

CNMD

Electromedical & Electrotherapeutic Apparatus

CONMED Corporation

Quality

8.3

out of 10

Value Trap

—

Price

$35.70

Last close

Models

11/13

Active

CV

Electromedical & Electrotherapeutic Apparatus

CapsoVision, Inc.

Quality

5.7

out of 10

Value Trap

—

Price

$6.78

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	CNMD Fair Value	CNMD Upside	CV Fair Value	CV Upside
Bayesian DCF	Intrinsic	$19.68	-44.9%	$0.14	-98.0%
Earnings Power Value	Intrinsic	—	—	$0.32	-95.7%
EROIC Spread	Intrinsic	$22.65	-36.6%	$2.03	-72.9%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CNMD vs CV — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CNMD vs CV — Which Stock Is More Undervalued?

CNMD scores higher with a 8.3/10 quality rating vs CV's 5.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing CONMED Corporation (CNMD) and CapsoVision, Inc. (CV) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CNMD currently trades at $35.70 with a QOC of 8.3/10, while CV trades at $6.78 with a QOC of 5.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).